Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,886 | 248 | 98.8% |
| Education | $47.23 | 3 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $691.72 | 58 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $527.86 | 40 | $0 (2020) |
| ABBVIE INC. | $359.82 | 29 | $0 (2024) |
| Lundbeck LLC | $343.64 | 18 | $0 (2020) |
| Neurocrine Biosciences, Inc. | $309.31 | 13 | $0 (2019) |
| Allergan, Inc. | $271.43 | 22 | $0 (2020) |
| Vanda Pharmaceuticals Inc. | $260.17 | 11 | $0 (2020) |
| Neos Therapeutics, LP | $238.83 | 11 | $0 (2019) |
| Shire North American Group Inc | $237.03 | 15 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $131.75 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $222.78 | 17 | ABBVIE INC. ($196.42) |
| 2023 | $274.92 | 18 | ABBVIE INC. ($163.40) |
| 2020 | $213.18 | 11 | Sunovion Pharmaceuticals Inc. ($47.67) |
| 2019 | $1,194 | 71 | Takeda Pharmaceuticals U.S.A., Inc. ($335.86) |
| 2018 | $1,185 | 84 | Takeda Pharmaceuticals U.S.A., Inc. ($339.75) |
| 2017 | $843.65 | 50 | Sunovion Pharmaceuticals Inc. ($155.43) |
All Payment Transactions
251 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.72 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.05 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.34 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.60 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.29 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.95 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.55 | General |
| Category: NEUROSCIENCE | ||||||
| 03/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: NEUROSCIENCE | ||||||
| 02/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.80 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: NEUROSCIENCE | ||||||
| 01/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.65 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.60 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.62 | General |
| Category: NEUROSCIENCE | ||||||
| 09/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.71 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2023 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: Neurology | ||||||
| 08/10/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 102 | 662 | $180,395 | $50,862 |
| 2022 | 2 | 98 | 621 | $169,350 | $48,643 |
| 2021 | 2 | 86 | 512 | $139,520 | $36,468 |
| 2020 | 3 | 111 | 438 | $96,931 | $24,046 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 51 | 331 | $104,265 | $33,088 | 31.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 51 | 331 | $76,130 | $17,774 | 23.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 312 | $98,280 | $31,490 | 32.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 49 | 309 | $71,070 | $17,153 | 24.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 43 | 256 | $80,640 | $23,174 | 28.7% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 43 | 256 | $58,880 | $13,294 | 22.6% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 42 | 219 | $40,021 | $11,065 | 27.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 40 | 166 | $49,355 | $11,052 | 22.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 29 | 53 | $7,555 | $1,930 | 25.5% |
About Dr. Mikhail Meyerovich, MD
Dr. Mikhail Meyerovich, MD is a Family Medicine healthcare provider based in Santa Barbara, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1073506952.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mikhail Meyerovich, MD has received a total of $3,933 in payments from pharmaceutical and medical device companies, with $222.78 received in 2024. These payments were reported across 251 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,886).
As a Medicare-enrolled provider, Meyerovich has provided services to 397 Medicare beneficiaries, totaling 2,233 services with total Medicare billing of $160,019. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Psychiatry
- Location Santa Barbara, CA
- Active Since 08/26/2005
- Last Updated 10/02/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1073506952
Products in Payments
- VRAYLAR (Drug) $631.25
- Trintellix (Drug) $621.69
- LATUDA (Drug) $527.86
- INGREZZA (Drug) $309.31
- REXULTI (Drug) $305.80
- Adzenys XR-ODT (Drug) $238.83
- VYVANSE (Drug) $167.56
- Hetlioz (Drug) $139.33
- Fanapt (Drug) $90.34
- APLENZIN (Drug) $88.17
- MYDAYIS (Drug) $85.58
- TRINTELLIX (Drug) $85.58
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $85.54
- Vyvanse (Drug) $68.44
- BELSOMRA (Drug) $66.84
- NUEDEXTA (Drug) $63.96
- BRINTELLIX (Drug) $40.61
- SUBOXONE SUBLINGUAL FILM (Drug) $34.63
- NeuroStar TMS Therapy (Device) $33.56
- FANAPT (Drug) $30.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Santa Barbara
Dr. Susan Lawton, M.d, M.D
Family Medicine — Payments: $7,601
David Phreaner, M.d, M.D
Family Medicine — Payments: $5,543
Randall Howard, M.d, M.D
Family Medicine — Payments: $4,640
Kari Mathison, M.d, M.D
Family Medicine — Payments: $4,260
Dr. Autumn Edwards, M.d, M.D
Family Medicine — Payments: $3,870
Jay Winner, M.d, M.D
Family Medicine — Payments: $3,716